Boston Partners’s Change Healthcare Inc. Common Stock CHNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,929,212
Closed -$80.5M 787
2022
Q3
$80.5M Sell
2,929,212
-4,158,905
-59% -$103M 0.12% 191
2022
Q2
$164M Buy
7,088,117
+15,733
+0.2% +$367K 0.23% 142
2022
Q1
$156M Buy
7,072,384
+989,782
+16% +$20.6M 0.19% 163
2021
Q4
$130M Buy
6,082,602
+933,892
+18% +$19.6M 0.16% 187
2021
Q3
$108M Buy
5,148,710
+340,567
+7% +$7.43M 0.14% 199
2021
Q2
$111M Buy
4,808,143
+2,754
+0.1% +$63.4K 0.14% 197
2021
Q1
$107M Sell
4,805,389
-9,850,272
-67% -$228M 0.14% 196
2020
Q4
$273M Sell
14,655,661
-365,349
-2% -$6M 0.43% 78
2020
Q3
$218M Sell
15,021,010
-206,601
-1% -$2.63M 0.4% 85
2020
Q2
$170M Buy
15,227,611
+2,474,813
+19% +$27.8M 0.31% 103
2020
Q1
$127M Buy
12,752,798
+2,056,026
+19% +$28.7M 0.25% 119
2019
Q4
$175M Buy
10,696,772
+3,268,133
+44% +$43.8M 0.23% 125
2019
Q3
$89.8M Buy
7,428,639
+365,090
+5% +$5.01M 0.12% 196
2019
Q2
$103M Buy
+7,063,549
New +$105M 0.14% 188

Other funds holding CHNG

Boston Partners's CHNG Position: Q4 2022 in Review

Boston Partners sold out of Change Healthcare Inc. Common Stock (CHNG) in Q4 2022, closing a stake of 2,929,212 shares — an estimated $80.5M sold.

Boston Partners first reported a position in CHNG in Q2 2019 and held it in 14 quarters. The position peaked at $273M in Q4 2020. 1 fund tracked by Wall St. Rank holds CHNG as of Q4 2022.

  • Boston Partners reported no remaining Change Healthcare Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Boston Partners sold 2,929,212 Change Healthcare Inc. Common Stock shares in Q4 2022, an estimated $80.5M.
  • Boston Partners first reported a position in Change Healthcare Inc. Common Stock in Q2 2019 and held it in 14 quarters.
  • Boston Partners's Change Healthcare Inc. Common Stock position peaked at $273M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held Change Healthcare Inc. Common Stock as of Q4 2022.

Based on Boston Partners's 13F filing for Q4 2022, filed 8 Feb 2023.